Surrozen, Inc. DE (SRZNW)
2025-06-30 | ||||
|---|---|---|---|---|
| Research service revenue - related party | 983 | |||
| Research and development | 6,042 | |||
| General and administrative | 3,958 | |||
| Total operating expenses | 10,000 | |||
| Loss from operations | -9,017 | |||
| Interest income | 1,025 | |||
| Gain on change in fair value of tranche liability | 31,520 | |||
| Loss on issuance of common stock, pre-funded warrants and warrants in the 2024 pipe | - | |||
| Loss on execution of the 2025 pipe | - | |||
| Loss on amendment and cancellation of warrants | - | |||
| Gain on settlement of tranche liability | - | |||
| Other income, net (note 3) | 16,218 | |||
| Net income (loss) | 39,700 | |||
| Earnings per share, basic | 2.55 | |||
| Earnings per share, diluted | 2.55 | |||
| Weighted average number of shares outstanding, basic | 8,541 | |||
| Weighted average number of shares outstanding, diluted | 8,541 | |||